The importance of being receptive

Journal of Neuroimmunology

Volumn 100, Issue 1-2, 1999, Pages 197-202

  Heijnen, Cobi J ^a   Kavelaars, Annemieke ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adrenergic receptor; Glucocorticoid receptor; Inflammation; Psychoneuroimmunology; Receptor regulation; Rheumatoid arthritis

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; CATECHOLAMINE; CHEMOKINE RECEPTOR; CYTOKINE; GLUCOCORTICOID RECEPTOR; HORMONE RECEPTOR; MUSCARINIC RECEPTOR; NEUROKININ; NEUROPEPTIDE; RECEPTOR SUBTYPE; SUBSTANCE P; TERBUTALINE;

ADAPTATION; CELL COMMUNICATION; CYTOKINE PRODUCTION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; MONOCYTE; MOUSE; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; REVIEW;

EID: 0033386989     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00194-0     Document Type: Article

References (44)

1. Abrass C.K., O'Connor S.W., Scarpae P.J., Abrass I.B. Characterization of the β-adrenergic receptor of the rat peritoneal macrophage. J. Immunol. 135:1985;1338-1341.
2. Baerwald C., Grafee C., Von Wichert P., Krause A. Decreased density of β-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis. J. Rheumatol. 19:1992;204-210.
3. Bellinger D.L., Lorton D., Romano T.D., Olschowka J.A., Felten S.Y., Felten D.L. Neuropeptide innervation of lymphoid organs. Ann. N. Y. Acad. Sci. 594:1990;17-33.
4. Bisphoric N.H., Cohen H.J., Lefkowitz R.J. Beta-adrenergic receptors in lymphocyte subpopulations. J. Allergy Clin. Immunol. 65:1980;29-33.
5. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo R.R.J., Trendelenburg U. International union of pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46:1994;121-136.
6. Casale T.B., Kaliner M. Demonstration that circulating human blood cells have no detectable α1-adrenergic receptors by ligand binding analysis. J. Allergy Clin. Immunol. 742:1984;812-819.
7. Chuang T.T., Iacovelli L., Sallese M., De Blasi A. G-protein coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol. Sci. 17:1996;416-421.
8. Cook G.A., Elliott D., Metwali A., Blum A.M., Sandor M., Lynch R., Weinstock J.V. Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor. J. Immunol. 152:1994;1830-1835.
9. Francis S.J., Walker R.F., Riad-Fahmy D., Hughes D., Murphy J.F., Gray O.P. Assessment of adrenal cortical activity in term newborn infants using salivary cortisol determinants. J. Pediatr. 111:1987;129-133.
10. Gong J.H., Ratkay L.G., Waterfield J.D., Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J. Exp. Med. 186:1997;131-136.
11. Goode T., O'Connel J., Sterinin C., Anton P., Wong H., O'Sullivan G.C., Collins J.K., Shanahan F. Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: molecular quantitation and localization. J. Immunol. 161:1998;2232-2240.
12. Hanna C.E., Keith L.D., Cloasurdo M.A., Bufkin D.C., Laird M.R., Mandel S.H., Cook S.H., LaFranchi S.H., Reynolds J.W. Hypothalamic pituitary adrenal function in the extremely low birth weight infant. J. Clin. Endocrinol. Metab. 76:1993;384-387.
13. Hartung H.P., Wolters K.V., Toyka K.V. Substance P binding properties and studies on cellular responses in guinea pig monocytes. J. Immunol. 136:1986;3856-3863.
14. Hausdorff W.P., Caron M.G., Lefkowitz R.J. Turning off the signal: desensitization of β-adrenergic receptor functioning. FASEB J. 4:1990;2881-2889.
15. Heijnen C.J., Rouppe van der Voort C., Wulffraat N., van der Net J., Kuis W., Kavelaars A. Functional α1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J. Neuroimmunol. 71:1996;223-226.
16. Jeurissen F., Kavelaars A., Korstjens M., Broeke D., Franklin R.A., Gelfand E.W., Heijnen C.J. Monocytes express a non neurokinin substance P receptor that is functionally coupled to MAP kinase. J. Immunol. 152:1994;2987-2993.
17. Kavelaars A., Broeke D., Jeurissen F., Kardux J., Meijer A., Franklin R., Gelfand E.W., Heijnen C.J. Activation of human monocytes via a non-neurokinin substance P receptor that is coupled to Gi protein, calcium, phospholipase D, MAP kinase and IL-6 production. J. Immunol. 153:1994;3691-3699.
18. Kavelaars A., Jeurissen F., Heijnen C.J. Substance P receptors and signal transduction in leukocytes. ImmunoMethods. 5:1994;41-48.
19. Kavelaars A., Zijlstra J., Bakker J.M., Van Rees E.P., Visser G.H.A., Zegers B.J.M., Heijnen C.J. Increased dexamethasone sensitivity of neonatal leukocytes: different mechanisms of glucocorticoid inhibition of T cell proliferation in adult and neonatal cells. Eur. J. Immunol. 25:1995;1346-1351.
20. Kavelaars A., Cats B., Visser G.H.A., Zegers B.J.M., Bakker J.M., Van Rees E.P., Heijnen C.J. Ontogeny of the response of human peripheral blood T cells to glucocorticoids. Brain Behav. Immunol. 10:1996;288-297.
21. Kavelaars A., Van de Pol M., Zijlstra J., Heijnen C.J. β2-Adrenergic receptor activation stimulates the production of IL-8 by human monocytes. J. Neuroimmunol. 77:1997;211-216.
22. Lane S.J., Lee T.H. Mechanisms of corticosteroid resistance in asthmatic patients. Int. Arch. Allergy Immunol. 113:1997;193-195.
23. Lane S.J., Adcock I.M., Richards D., Hawroylowicz C., Barnes P.J., Lee T.H. Corticosteroid resistant asthma is associated with increased c-fos expression in monocytes and T lymphocytes. J. Clin. Invest. 102:1998;2156-2164.
24. Lee M., Rajagopalan L., Berg G.J., Moshang T.J. Serum and adrenal steroid concentrations in premature infants. J. Clin. Endocrinol. Metab. 69:1989;1133-1136.
25. Lefkowitz R.J., Stadel J.M., Caron M.G. Adenylate cyclase-coupled β-adrenergic receptors: structure and mechanism of activation and desensitization. Annu. Rev. Biochem. 52:1983;159-186.
26. Leung D.Y., Hamid Q., Vottero A., Szelfer S.J., Surs W., Minshall E., Chrousos G.P., Klemm D.J. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J. Exp. Med. 186:1997;1567-1574.
27. Levine J.D., Clark R., Devor M., Helms C., Moskowitz M.A., Basbaum A. Intraneuronal substance P contributes to the severity of experimental arthritis. Science. 226:1984;547-549.
28. Levine J.D., Codere T.J., Helms C., Basbaum A.I. b2-adrenergic mechanisms in experimental arthritis. Proc. Natl. Acad. Sci. U.S.A. 85:1988;4553-4556.
29. Lombardi M.S., Kavelaars A., Schedlowski M., Bijlsma J.W.J., Okihara K., Van de Pol M., Ochsmann S., Pawlak C.R., Schmidt R.E., Heijnen C.J. Decreased expression and activity of G protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J. 13:1999;715-725.
30. Penix L., Ruiz-Gomez A., Castano J.G., Mayor F.j. Degradation of the G protein-coupled receptor kinase 2 by the proteasome pathway. J. Biol. Chem. 273:1998;35238-35244.
31. Pernow B. Substance P. Pharmacol. Rev. 5:1983;85-141.
32. Plater-Zybeck C., Hoogewerf A.J., Proudfoot A.E., Power C.A., Wells T.N. Effects of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol. Lett. 57:1999;117-120.
33. Regioli D., Drapeau G., Dion S., D'Orleans-Juste P. Receptors for substance P and related neurokinins. Pharmacology. 38:1989;1-12.
34. Rijkers G.T., Sanders E.A.M., Breukels M.A., Zegers B.J.M. Responsiveness of infants to capsular polysaccharides: implications for vaccine development. Rev. Med. Microbiol. 7:1996;3-12.
35. Rouppe van der Voort C., Kavelaars A., Van de Pol M., Heijnen C.J. Neuroendocrine mediators up-regulate α1b- and α1d-adrenergic receptor subtypes in human monocytes. J. Neuroimmunol. 95:1999;165-173.
36. Sippell W.G., Becker H., Versmold H.T., Bidlingmaier F., Knorr D. Longitudinal studies of plasma aldosterone, corticosterone, deoxycorticosterone, progesterone, cortisol, and cortisone determined simultaneously in mother and child at birth and during the early neonatal period: I. Spontaneous delivery. J. Clin. Endocrinol. Metab. 46:1978;971-985.
37. Splawski J.B., Jelinek D.F., Lipsky P.E. Delineation of the functional capacity of human neonatal lymphocytes. J. Clin. Invest. 87:1991;545-553.
38. Stanisz A., Scicchitano P., Dazin J., Bienenstock J., Payan D.G. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J. Immunol. 139:1987;749-754.
39. Stead R. Innervation of mucosal immune cells in the gastrointestinal tract. Reg. Immunol. 4:1992;91-99.
40. Ungerer M., Bohm M., Elce J.S., Erdmann E., Lohse M.J. Altered expression of beta-adrenergic receptor kinase and beta1-adrenergic receptors in the failing human heart. Circulation. 87:1999;454-463.
41. Van der Poll T., Coyle S.M., Barbosa K., Braxton C.C., Lowry S.F. Epinephrine inhibits tumor necrosis factor-a and potentiates interleukin-10 production during human endotoxemia. J. Clin. Invest. 97:1996;713-719.
42. Watson W., Oen K., Ramdahin R., Harman C. Immunoglobulin and cytokine production by neonatal lymphocytes. Clin. Exp. Immunol. 83:1991;169-174.
43. 1-adrenoceptor subtypes to phospholipase C and mitogen activated protein kinase in neonatal rat cardiac myocytes. Eur. Pharmacol. 339:1997;77-86.
44. Whang X., Luo H., Chen H., Duguid W., Wu J. Role of proteasomes in T cell activation and proliferation. J. Immunol. 160:1998;788-801.